Invitris Logo

Enabling the protein era

Shaping the future of drug discovery through cell-free expression and AI-driven design

Supported By

Logo 1
Logo 2
Logo 3
Logo 4
Logo 5
Logo 6
Logo 7
Logo 1
Logo 2
Logo 3
Logo 4
Logo 5
Logo 6
Logo 7
Technology

Invitris: The cell free company

We are redefining the future of biotechnology with cell-free protein synthesis. Our universal platform enables rapid design, expression, and scalable production of even the most complex proteins and unlocking breakthroughs beyond the limits of cell-based systems.

Invitris Cell-Free Technology
20x
Faster protein synthesis
30x
Higher turnaround
100%
High flexibility and tunability
Unlimited possibilities

Prokaryotic Cell-Free Expression System

  • High-yield protein expression with streamlined purification using Phactory™ reagents
  • Optimized for microbial proteins including enzymes, phages, endolysins, tailocins, and binders
  • Supports E. coli codon-optimized DNA with T7 promoters for consistent, scalable results

Mammalian Cell-Free Expression System

  • Enables production of complex proteins with post-translational modifications like glycosylation and disulfide bonds
  • Bypasses complex transfection protocols for faster workflows
  • Delivers scalable, high-yield expression of difficult-to-express proteins

Cell-free protein synthesis

Leverage advanced cell-free systems for rapid, flexible protein production

Ultra high-throughput

Harness microfluidics to screen up to 1,000 proteins per second

Rapid protein engineering (Sequence to structure)

Integrate computational design with high-throughput screening

Translational protein production

Seamlessly scale from picoliter reactions to liter-scale

Features

Our Solutions

We partner across life sciences to tackle challenges and enable innovation in research and development

Markets

Advancing innovation across sectors

Our technologies adapt to diverse industry needs, driving innovation from research to real-world application

Biopharmaceuticals

Biopharmaceuticals

Accelerating drug discovery and therapeutic development

AMR and Phage production

AMR and Phage production

Targeted phage engineering to combat AMR

Industrial Biotechnology

Industrial Biotechnology

Enabling efficient solutions for enzyme production

Agriculture

Agriculture

Innovative solutions for sustainable agriculture

Research Collaboration
Partnership

Co-development & Licensing

Accelerate discovery with joint research, co-development, and flexible licensing to turn ideas into market-ready solutions.

Industrial Manufacturing
Partnership

Scalable Biotech Production

Scale seamlessly from cell-free validation to GMP manufacturing with advanced, reliable, and efficient production technologies.

Read the latest
from Invitris

You shall not pass: Wie zellfreie Moleküle das Böse bekämpfen

You shall not pass: Wie zellfreie Moleküle das Böse bekämpfen

Invitris wins EIC grant

Invitris wins EIC grant

Invitris receives 250,000 euros for complete spin-off from TUM

Invitris receives 250,000 euros for complete spin-off from TUM

Invitris in one of the largest daily newspapers in 🇩🇪 !

Invitris in one of the largest daily newspapers in 🇩🇪 !

Contact Us

Ready to explore how our biotechnology solutions can advance your projects? Let's discuss your needs and discover the possibilities together.

Please contact us via contact@invitris.com.